TESTS OF HEPATIC FUNCTION
Although the liver performs a great variety of presumably testable functions, it has proved difficult to devise a test that is simple, cheap, reproducible, and noninvasive and that accurately reflects hepatic capacity for all functions. Instead,currently available tests of liver function are indirect, static measurements of serum levels of compounds that are synthesized, metabolized, and/or excreted by the liver. In interpreting these tests, it is important to remember that the liver has a large reserve capacity, and therefore “function” tests may remain relatively normal until liver dysfunction is severe. Table 43-2 outlines the most available and useful liver function tests. The serum albumin level and prothrombin time both reflect the hepatic capacity for protein synthesis, although changes in these proteins are not specific for liver disease. The prothrombin time responds rapidly to altered hepatic function because the serum half-lives of Factors II and VII are short (hours). In contrast, the serum half-life of albumin is 14 to 20 days, and serum levels fall only with prolonged, severe liver dysfunction.
Serum bile acid levels, particularly when measured two hours after a meal, have proved to be the most sensitive test of liver disease, and this is due to the high efficiency with which the liver normally extracts bile acids from portal blood. Small changes in hepatic blood flow, portosystemic shunting, or liver function all result in a substantial elevation of serum bile acid levels, while terminal ileal dysfunction (e.g., Crohn’s disease] leads to fecal loss of bile acids and decreased serum levels. Although exquisitely sensitive, bile acid levels are nonspecific and fail to reflect accurately overall liver function.
The 14C-aminopyrine breath test was originally developed as a true test of liver function. It measures the rate at which the liver metabolizes 14C-labeled aminopyrine to 14C02, which is collected and measured in exhaled breath. This test is performed in some academic centers and may be useful in following the progression of liver disease in an individual patient.
- Diagnosis
- Membranoproliferative Glomerulonephritis (MPGN)
- CLINICAL TESTS OF DIGESTION AND ABSORPTION
- Renal Tumors
- Aminoaciduria
- LIVER BIOPSY
- AORTIC DISEASE - AORTIC ANEURYSMS
- SPECIFIC ARRHYTHMIAS - sinus nodal rhythm disturbances
- ATHEROSCLEROSIS
- CLINICAL SYMPTOMS OF ESOPHAGEAL DISEASE
- LABORATORY TESTS OF LIVER FUNCTION AND DISEASE
- Membranous Glomerulopathy
- CHRONIC RENAL FAILURE
- Reduction in GFR
- Hepatorenal Syndrome
- PRE-EXCITATIOIi SYNDROMES
- MEDIASTINITIS
- Skin and Conjunctiva
- TREATMENT
- Other Glomerulonephritides
- MICROSCOPIC ANATOMY
- COMPLICATIONS OF MYOCARDIAL INFARCTION AND THEIR MANAGEMENT
- CHARACTERISTICS OF ABDOMINAL PAIN
- NAUSEA AND VOMITING
- CARCINOMA OF THE COLON
- SCREENING TESTS OF HEPATOBILIARY DISEASE
- Etiology and Pathogenesis
- Community Acquired Pneumonia
- THE APPROACH TO THE PATIENT WITH GASTROINTESTINAL HEMORRHAGE
- SPECIFIC MANIFESTATIONS OF RENAL DISEASE
- PHYSIOLOGY OF THE CORONARY CIRCULATION
- RENAL PHARMACOLOGY
- CARDIOVASCULAR PHYSIOLOGY DURING PREGNANCY - ELECTROPHYSIOLOGY
- FACTORS AFFECTING THE RATE OF LOSS OF NEPHRONS
- Bleeding Diatheses